Omni Pharmaceuticals Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series D

  • Investors
  • 11

Omni Pharmaceuticals General Information

Description

Manufacturer of generic and branded pharmaceuticals designed to focus on chronic diseases like Chronic Obstructive Pulmonary Disease (COPD) and asthma. The company's generic and branded pharmaceuticals which include inhalation dry powder, nasal and HFA aerosol and sustained release capsules and tablets are featured in drug delivery systems that are difficult to develop, manufacture, and replicate for regulated markets and for the China market, enabling regulated markets of North America, Europe and China to contribute their expertise and solve selected public health challenges.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Primary Office
  • Room 2915-2916, Gong Shang Lian Building
  • 55 Yan An Road (East), Huangpu District
  • Shanghai, 201203
  • China
+86 021 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Omni Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D) 27-Dec-2021 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 01-Oct-2017 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 22-Sep-2015 Completed Startup
1. Early Stage VC (Series A) 01-Mar-2013 Completed Startup
To view Omni Pharmaceuticals’s complete valuation and funding history, request access »

Omni Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of generic and branded pharmaceuticals designed to focus on chronic diseases like Chronic Obstructive Pulmo
Pharmaceuticals
Shanghai, China
000.00
00000000000 000.00

000000

pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui off
000000000000000
New Delhi, India
00000 As of 0000
00000
0000 0000-00-00
00000000 00000

000000

e irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat n
000000000000000
Berkeley Heights, NJ
00 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Omni Pharmaceuticals Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mankind Pharma Formerly PE-Backed New Delhi, India 00000 00000 00000000 00000
00000000 Corporation Berkeley Heights, NJ 00 000.00 00000000 000.00
00000 Corporation Mumbai, India 00000 000000000
00000000 Corporation Basel, Switzerland 000000 0000 000000000 0000
000000 Corporation Paris, France 00000 00.00 000000000 00.00
To view Omni Pharmaceuticals’s complete competitors history, request access »

Omni Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Kai Zhang Ph.D Co-Founder & Chairman
Shaochuan Zeng Co-Founder & Chief Operating Officer
To view Omni Pharmaceuticals’s complete executive team members history, request access »

Omni Pharmaceuticals Board Members (1)

Name Representing Role Since
Kai Zhang Ph.D Omni Pharmaceuticals Co-Founder & Chairman 000 0000
To view Omni Pharmaceuticals’s complete board members history, request access »

Omni Pharmaceuticals Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bank of China Group Investment PE/Buyout Minority 000 0000 000000 0
Origins Capital Venture Capital Minority 000 0000 000000 0
Shanghai Healthcare Capital PE/Buyout Minority 000 0000 000000 0
Shanghai Zhangjiang Science & Technology Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
SIIC Holdings Government Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »